Among the phase-variable genes, there are genes encoding DNA methyltransferases (Mod) belonging to the type III restriction-modification systems
This Review, therefore, aims to provide a theoretical framework for the potential consequences of tissue build-up of LCACs among individuals with metabolic disorders
These can be severe enough to deter some people from continuing the medication
Related Reading Glp 1 Medications Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications Maximus Glp 1 Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
It carries a BBB F non-accredited rating